Trovan Patent Expiration

Trovan is a drug owned by Pfizer Central Research. It is protected by 2 US drug patents filed in 2013 out of which all have expired. Based on its patents and exclusivities, its generic launch date is estimated to be Jan 20, 2019. Details of Trovan's patents and their expiration are given in the table below.

Drug Patent Number Drug Patent Title Drug Patent Expiry Status
These drug patents focus on the other aspects of the drug like dosage, mode of administration (oral, tablet, capsules, liquids etc).
US6187341 Trovafloxacin mesylate tablet
Jan, 2019

(5 years ago)

Expired
US5763454 Crystal form of anhydrous 7-( 1α,5α,6α!-6-amino-3-azabicyclo 3.1.0!hex-3-yl)-6-fluoro-1-(2,4-difluorophenyl)-1,4-dihydro-4-oxo-1,8 naphthyridine-3-carboxylic acid, methanessulfonic acid salt
Jun, 2015

(9 years ago)

Expired

Stay ahead of others in designing the generic launch strategy of these 5 blockbuster drugs expiring in next 5 years.

Get the exclusive patent insights now. Don't be the last to know.

US patents provide insights into the exclusivity only within the United States, but Trovan is protected by patents in multiple countries. Understanding the full scope of patent protection is crucial in strategizing market entry. By looking at the broader patent landscape, you can identify markets with weaker patent protection which could be ideal generic entry points. The following section offers details on Trovan's family patents as well as insights into ongoing legal events on those patents.

Trovan's Family Patents


Family Patents

Explore Our Curated Drug Screens

Drugs Generating Over $1 Billion in Annual Revenue
Explore the top-performing drugs that dominate the pharmaceutical industry
View List
NCE-1 Patent Expiry in the Next 1 Year
Identify opportunities as new chemical entity (NCE-1) patents approach expiry
View List
Recently Granted Patents in EP
Find the opportunity to file Oppositions
View List


Generic Launch

Generic Release Date:

Trovan's generic launch date based on the expiry of its last outstanding patent is estimated to be Jan 20, 2019 (This date is subject to change depending upon the patent filing activities by the drug owner or exclusivity additions to its drug application)

Trovan Generics:

There are no approved generic versions for Trovan as of now.

Alternative Brands for Trovan

Trovan which is used for treating bacterial infections., has several other brand drugs in the same treatment category . Given below is the list of those companies and their brand drugs, to help you identify new opportunities, assess competitors, and plan your market strategies more effectively.

Drug Owner Drug Name Treatment Area
Abbvie
Teflaro Used for treating bacterial infections.
Baxter Hlthcare Corp
Zosyn In Plastic Container used for treating bacterial infections.
Cubist Pharms Llc
Cubicin Used for treating bacterial infections, including skin infections and bloodstream infections.
Sivextro Used for treating acute bacterial skin and skin structure infections caused by susceptible bacteria.
Cumberland
Vibativ Used for treating bacterial infections, including staphylococcal infections.
Lg Chem Ltd
Factive used for treating various bacterial infections.
Pfizer
Trovan Preservative Free Used for treating bacterial infections.
Pf Prism Cv
Zmax used for treating bacterial infections.
Tygacil Used for treating bacterial infections.
Rempex
Minocin used for treating bacterial infections.
Shionogi Inc
Doribax Used for treating bacterial infections.
Wyeth Pharms
Zosyn Used for treating bacterial infections.
Xellia Pharms Aps
Vancomycin Used for treating bacterial infections.
Vancomycin Hydrochloride Used for treating bacterial infections.





About Trovan

Trovan is a drug owned by Pfizer Central Research. It is used for treating bacterial infections. Trovan uses Trovafloxacin Mesylate as an active ingredient. Trovan was launched by Pfizer in 1997.

Approval Date:

Trovan was approved by FDA for market use on 18 December, 1997.

Active Ingredient:

Trovan uses Trovafloxacin Mesylate as the active ingredient. Check out other Drugs and Companies using Trovafloxacin Mesylate ingredient

Treatment:

Trovan is used for treating bacterial infections.

Dosage:

Trovan is available in tablet form for oral use. Given below is detailed information on Dosage -

Strength Dosage Form Availability Application Pathway
EQ 200MG BASE TABLET Discontinued ORAL
EQ 100MG BASE TABLET Discontinued ORAL